Evidence map›Paper›PMID 41835103›Full record

ArticleNeurology (E-Cronicon)2025

Neurogenetics and Epigenetics of Spirituality and Religion: Seeking Genospirituality Via the Lens of Hierarchical Neuro-Spiritual Model (HNSM).

Kai-Uwe Lewandrowski, Kenneth Blum, Morgan P Lorio, Alireza Sharafshah, Albert Pinhasov, Panayotis K Thanos, Catherine A Dennen, Igor Elman, David Baron, Alexander Pl Lewandrowski and 12 more

Abstract read
In one paragraph

Article in Neurology (E-Cronicon), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Kai-Uwe LewandrowskiDivision of Personalized Pain Therapy Research and Education, Center for Advanced Spine Care of Southern Arizona, Tucson, AZ, USA.
Kenneth BlumDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Morgan P LorioAdvanced Orthopedics, Altamonte Springs, On Behalf of the International Society for the Advancement of Spine Surgery, Orlando College of Osteopathic Medicine, Orlando, FL, USA.
Alireza SharafshahCellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Albert PinhasovDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Panayotis K ThanosDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Catherine A DennenDepartment of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA.
Igor ElmanDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
David BaronDivision of Addiction Research and Education, Center for Sports, Exercise, and Mental Health, Western University of Health Sciences, Pomona, CA, USA.
Alexander Pl LewandrowskiDornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.
Alexander R VaccaroChairman of the Department of Orthopaedic Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Óscar L AlvesHead of Neurosurgery, Hospital Lusíadas Porto, Senior Consultant in Neurosurgery, ULS Gaia Espinho, Portugal.
Milan T MakaleDepartment of Radiation Medicine and Applied Sciences, UC San Diego, La Jolla, CA, USA.
Rajendra D BadgaiyanDepartment of Psychiatry, Texas Tech University Health Science Center, Midland, TX, USA.
Gianni MartireDivision of Clinical Neurology, The Blum Institute of Neurogenetics and Behavior, Austin, TX, USA.
Thomas SimpaticoDepartment of Psychiatry, University of Vermont, School of Medicine, Burlington, VT, USA.
Abdalla BowirratDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Albert PinhasovDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
William J HeaneyDivision of Clinical Neurology, The Blum Institute of Neurogenetics and Behavior, Austin, TX, USA.
Debasis BagchiDepartment of Pharmaceutical Sciences, Texas Southern University College of Pharmacy, Houston, TX, USA.
Rossano Kepler Alvim FiorelliDepartment of General and Specialized Surgery, Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro-RJ, Brazil.
Sergio Luis SchmidtDepartment of Neurology, Federal University of the State of Rio de Janeiro (UNIRIO), RJ, Brazil.

Funding

AFFECTIVE AND CONATIVE CHANGES IN ALCOHOLISMR01AA007112 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERMAN, MARLENE OSCAR · 1987 to 2019
$8.3M
AFFECTIVE AND CONATIVE CHANGES IN ALCOHOLISMK05AA000219 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERMAN, MARLENE OSCAR · 1997 to 2011
$1.8M
A Systematic Medical Approach to Reward Transformation (SMART) for Brain Health in Opioid Use DisorderR41MD012318 · NIMHD · VERSA INTEGRATED SOLUTIONS, INC. · PI BLUM, KENNETH, GONDRE-LEWIS, MARJORIE C · 2017 to 2017
$221k
NIAAA NIH HHS K05 AA000219NIAAA NIH HHS R01 AA007112NIMHD NIH HHS R41 MD012318
6 · The paper itself

Abstract

Addictive behaviors-including the misuse of tobacco, alcohol, illicit substances, and compulsive activities such as gambling, overeating, and sexual excess-remain widespread and profoundly burdensome on both individuals and societies. Their impact is multifaceted, encompassing adverse health outcomes, increased criminal activity, and significant economic costs due to lost productivity. Addiction is a highly complex condition shaped by genetic predispositions, environmental influences, and behavioral factors, all of which contribute to disruptions in neural regulation and compulsive decision-making. While advances have been made in identifying the genetic and biochemical underpinnings of addiction and related psychiatric disorders, progress in developing broadly effective therapies has been limited. Addiction is often characterized by feelings of fragmentation, helplessness, and existential despair-phenomena that may reflect a deeper, unmet need for personal integration, purpose, and transformation. This perspective supports the notion that spiritual yearning can be an integral part of the recovery process. Efforts to address addiction have frequently overlooked the potential therapeutic value of spirituality in fostering healing. If one accepts the premise that the brain governs both conscious and unconscious experience-including religious and spiritual phenomena-it follows that addiction, and mental illness may involve disrupted neural systems that regulate reward and suffering. We propose that individuals may have differing capacities for spiritual resilience or growth based on a dynamic interplay between their genetic architecture and epigenetic factors (e.g. life experiences, trauma, social environment). This expert opinion presents current evidence supporting this hypothesis and highlights the relevance of the Hierarchical Neuro-Spiritual Model (HNSM) as a novel framework for understanding the spiritual dimension in the pathophysiology and treatment of addiction.

Indexed as

Addiction RecoveryDopaminergicGenesHierarchical Neuro-Spiritual Model (HNSM)Reward Deficiency Syndrome (RDS)Reward DependenceSpiritualityTwelve Steps

Identifiers

PMID41835103
PMCPMC12981603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.